Skip to the card

Card 332 of 9982026-09-01 issue

Observed arrival · 2026-09-01

GLP-1 Atlas maps the practical life of weight-loss medicines

glp-1atlas.com Observed source
Editorial interest 78/100 Selection signal · not a rating of the site

A structured reference covering eight GLP-1 medicines, from dose schedules and missed doses to side effects, food, hydration, muscle, and stopping treatment.

Landing page captured for the 2026-09-01 issue.

Field notes

The reference is organized by both medicine and treatment moment: readers can compare products, inspect individual dose ladders, or jump directly to missed doses, side effects, food, hydration, muscle, and stopping treatment. The homepage identifies eight products spanning semaglutide, tirzepatide, liraglutide, and dulaglutide, and gives many explainers estimated at six to ten minutes. Its medical authority and update process are not established by the supplied extract.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

OpenPublic substance visible
PrettyNotable craft visible
ProPolished or operationally mature
NicheUnusually specific use

One card from the complete issue

Nobody Gets to See the Answer

315,616 arrived 1,000 judged 998 catalogued Enter the complete issue
glp-1atlas.com

Landing page observed 2026-09-01. The live site may have changed.